Although little is known about the role of IL-6 in the pathophysiology of IH leading to vein bypass graft failure, several studies have demonstrated that IL-6 is pro-atherogenic through promoting EC dysfunction, SMC proliferation and migration as well as recruitment and activation of inflammatory cells [50]–[53]. This evidence concerns the gene IL6 and isolated hemihyperplasia.